Tag: Aurigene
Aurigene wins RE Pharma award; contributes to two US FDA Novel...
In a significant milestone year, Aurigene also served as the primary API manufacturer for two of the 46 Novel Drug Approvals granted by the (USFDA) in 2025
Aurigene’s Dr Kesavan Balakumaran shares insights on scalable peptide manufacturing at...
The presentation highlighted the importance of selecting the right development approach based on project requirements, timelines, and scale
Aurigene unveils CHEESE database to speed up hit identification
New virtual library on CHEESE platform streamlines hit identification and boosts self-reliance in drug discovery
Aurigene showcases explainable AI and physics-based molecular design at Discovery and...
Combining XAI, molecular dynamics, and a 12-billion-compound universe, Aurigene.AI delivers breakthroughs from kinase inhibitors to bispecifics — all backed by lab validation
Aurigene’s Dr. Gayathri Ramaswamy showcases exciting data on rapid design &...
Dr Ramaswamy's presentation highlighted the potential of these molecules to accelerate drug discovery by enabling targeted protein degradation with enhanced specificity and efficiency
Aurigene Pharmaceutical introduces Aurigene.AI, an AIML assisted drug discovery platform
AI is an end-to-end solution for small molecule drug discovery combining AI and ML capabilities with Aurigene's core expertise in synthesizing and testing the molecules in vitro and in vivo
Aurigene & Curis plan clinical trial of CA-170 in India
Aurigene, a wholly owned subsidiary of Dr Reddy’s, and Curis have announced CA-170 program update following data presented at ESMO 2017. Results from 34 patients demonstrate positive safety profile and support decision to expand development.........